Propofol: Difference between revisions
No edit summary |
No edit summary |
||
| Line 30: | Line 30: | ||
==Pediatric Population== | ==Pediatric Population== | ||
#Safe for procedural sedation in pediatric patients. Same dosing. | #Safe for procedural sedation in pediatric patients. Same dosing. | ||
==See Also== | |||
[[Procedural Sedation]] | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 22:53, 3 July 2011
Background
- an ultrashort-acting sedative alkylphenol derivative that induces deep sedation
- rapid onset (90-100 seconds) and short duration (2-8 minute half-life)
Contraindications
- allergy to soy or eggs
- hypotension
- aortic stenosis
Higher Risk
- Patients >55 years old
- Debilitated patients
- Patients with significant underlying illness (i.e. ASA physical status score III or IV)
^Optimize volume status before administration
Side Effects
- Respiratory depression
- Transient hypotension
- Pain at injection site (inject lidocaine IV first)
Dose
- induction = 1mg/kg IV, followed by 0.5mg/kg every 2-3 minutes as needed
- Small incremental doses (10-30mg) can slowly be administered to effect
Adjunctive medications
- fentanyl or morphine (propofol does not provide analgesia)
- NS for transient hypotension
- Lidocaine flush (to reduce injection pain)
Pediatric Population
- Safe for procedural sedation in pediatric patients. Same dosing.
